Howard D P J
Oxford Radcliffe Hospitals Trust, Oxford, UK.
Int J Clin Pract. 2007 Feb;61(2):336-40. doi: 10.1111/j.1742-1241.2006.00863.x.
Venous thromboembolism (VTE) is a major cause of morbidity and mortality in the UK. Studies have shown that pulmonary embolism causes or contributes to approximately 1 in 10 hospital deaths of medical patients admitted to general hospitals in the UK (Lindblad B, Sternby NH, Bergqvist D. BMJ 1991; 302: 709-11), with pulmonary embolus being the most common preventable cause of hospital death. Thromboprophylaxis is safe, highly effective and cost effective, but despite various current clinical guidelines, physicians fail to prescribe prophylaxis for the majority of medical inpatients at risk of VTE. This article outlines the current evidence for VTE prophylaxis in medical patients and discusses the reasons behind the insufficient use of prophylaxis in the acute medical setting.
静脉血栓栓塞症(VTE)是英国发病和死亡的主要原因。研究表明,在英国综合医院收治的内科患者中,肺栓塞导致或促成了约十分之一的住院死亡(Lindblad B、Sternby NH、Bergqvist D.《英国医学杂志》1991年;302:709 - 11),肺栓塞是医院死亡最常见的可预防原因。血栓预防是安全、高效且具有成本效益的,但尽管有各种现行临床指南,医生仍未对大多数有VTE风险的内科住院患者开具预防药物。本文概述了内科患者VTE预防的当前证据,并讨论了在急性内科环境中预防措施使用不足背后的原因。